Anika Therapeutics ANIK Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Commercial Channel | $49.73M+2.7% | $48.41M+5.1% | $46.04M+5.0% | $43.87M+0.1% | $43.82M+4.0% | |
| OEM Channel | $66.53M+3.3% | $64.41M-3.5% | $66.76M-5.5% | $70.68M-3.5% | $73.23M-5.8% | |
| Revenue by Geography | ||||||
| Europe | $23.08M+3.9% | $22.21M+8.1% | $20.55M+4.4% | $19.68M-4.7% | $20.64M+6.4% | |
| Other Location | $20.95M+2.0% | $20.55M+7.4% | $19.13M+2.8% | $18.6M+3.5% | $17.98M-0.4% | |
| US | $72.27M+3.0% | $70.14M-4.1% | $73.17M-4.1% | $76.31M-2.8% | $78.47M-4.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Anika Therapeutics break its business down?
- Anika Therapeutics (ANIK) reports revenue by product across 2 parts — Commercial Channel and OEM Channel. Each is extracted from the segment footnotes and tracked over time.
- Where does Anika Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Anika Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
